DNA Sequencing Technologies within the Chemical and Biological Defense Enterprise: How to Position the Department of Defense to Maximize the Use of These Emerging Technologies - JUPITR
Abstract
To generate accurate and actionable disease data that can be integrated into the broader Department of Defense response framework, it is critical to anticipate looming advances in genomic sciences while ensuring that the most advanced molecular diagnostic capabilities are available to chemical and biological defense programs. The recommendations detailed in this report are based on the assessments of the current state-of-the-art technologies for genomic sequencing and on how these technologies mature and evolve. Six recommendations were made for the use and improvement of deoxyribonucleic acid sequencing technologies to better support chemical and biological defense capabilities. This report especially addresses the 2014 time frame of these technologies and their future estimation. This report also provides recommendations to assess new technologies while wisely allocating resources to respond to emerging biological threats that directly affect the health and performance of service members and the risks they face.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2015
- Accession Number
- ADA619148
Entities
People
- David L. Hirschberg
- Kelley Betts
- Peter Emanuel
- Rebecca Hutchins
Organizations
- Edgewood Chemical Biological Center